[go: up one dir, main page]

AU5674798A - P2 receptor agonists, antagonists and modulators of endogenous atp release - Google Patents

P2 receptor agonists, antagonists and modulators of endogenous atp release

Info

Publication number
AU5674798A
AU5674798A AU56747/98A AU5674798A AU5674798A AU 5674798 A AU5674798 A AU 5674798A AU 56747/98 A AU56747/98 A AU 56747/98A AU 5674798 A AU5674798 A AU 5674798A AU 5674798 A AU5674798 A AU 5674798A
Authority
AU
Australia
Prior art keywords
modulators
antagonists
receptor agonists
atp release
endogenous atp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56747/98A
Inventor
Wayne Barry Bowler
James Anthony Gallagher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Liverpool
Original Assignee
University of Liverpool
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Liverpool filed Critical University of Liverpool
Publication of AU5674798A publication Critical patent/AU5674798A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU56747/98A 1997-01-23 1998-01-23 P2 receptor agonists, antagonists and modulators of endogenous atp release Abandoned AU5674798A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9701374.2A GB9701374D0 (en) 1997-01-23 1997-01-23 Purinergic agonists and antagonists
GB9701374 1997-01-23
PCT/GB1998/000205 WO1998032429A2 (en) 1997-01-23 1998-01-23 P2 receptor agonists, antagonists and modulators of endogenous atp release for the treatment of skin conditions and the improvement of wound healing

Publications (1)

Publication Number Publication Date
AU5674798A true AU5674798A (en) 1998-08-18

Family

ID=10806475

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56747/98A Abandoned AU5674798A (en) 1997-01-23 1998-01-23 P2 receptor agonists, antagonists and modulators of endogenous atp release

Country Status (3)

Country Link
AU (1) AU5674798A (en)
GB (1) GB9701374D0 (en)
WO (1) WO1998032429A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0120704D0 (en) * 2000-09-01 2001-10-17 Glaxo Group Ltd Polypeptide
FR2826278B1 (en) * 2001-06-20 2005-03-25 Lipha USE OF ANTIDIABETIC AGENTS FOR MANUFACTURING A MEDICAMENT HAVING A HEALING EFFECT
DK1397124T3 (en) * 2001-06-20 2007-04-02 Merck Sante Sas Use of diabetic agents for the manufacture of a medicament having a healing effect
CA2480080C (en) 2002-04-09 2010-08-03 Otsuka Pharmaceutical Co., Ltd. Composition for cell proliferation
WO2004084895A2 (en) * 2003-03-27 2004-10-07 Medicure, Inc. Modulation of cell death
US7557093B2 (en) 2003-10-08 2009-07-07 Otsuka Pharmaceutical Co., Ltd. Composition for promoting collagen production
EP1767201B8 (en) * 2004-06-28 2012-02-29 Ajinomoto Co., Inc. Nutrient composition and composition for prevention/mitigation of digestive tract depression

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2844103B2 (en) * 1990-02-09 1999-01-06 株式会社コーセー External preparation for skin

Also Published As

Publication number Publication date
GB9701374D0 (en) 1997-03-12
WO1998032429A3 (en) 1999-04-01
WO1998032429A2 (en) 1998-07-30

Similar Documents

Publication Publication Date Title
AU5343298A (en) 5-ht2c receptor agonists and aminoalkylindazole derivatives
PL341091A1 (en) Agonists of adenosine receptor a1
AU5203999A (en) Beta3-adrenergic receptor agonists
IL135964A0 (en) Adenosine a1 receptor agonists
AU1052599A (en) Retinoid receptor agonists
AU6219398A (en) Use of central cannabinoid receptor antagonists for regulating appetence
IL149096A0 (en) Positive modulators of nicotinic receptor agonists
AU4713499A (en) Ophthalmic uses of ppargamma agonists and ppargamma antagonists
AU2056700A (en) 2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity
EP0979228A4 (en) Novel cannabinoid receptor agonists
AUPP380498A0 (en) Egf receptor agonists and antagonists
IL149098A0 (en) Positive modulators of nicotinic receptor agonists
AU5674798A (en) P2 receptor agonists, antagonists and modulators of endogenous atp release
AU9512298A (en) Beta3-adrenoreceptor agonists, agonist compositions and methods of using
AU5861900A (en) Receptor agonists and antagonists
AU3550697A (en) Aminocyclohexane derivatives as 5-ht receptor agonists
IL120759A0 (en) Modulators of the function of fas receptors and other proteins
AU1937300A (en) Indole derivatives and their use as 5-HT1F agonists
AU8570698A (en) T-cell receptor beta-like protein
AU3935897A (en) B1-bradykinin receptor antagonists and use thereof
AU1745501A (en) Positive modulators of nicotinic receptor agonists
AU3476599A (en) Indol-3-yl-cyclohexyl amine derivatives for the treatment of depression (5-ht1 receptor antagonists)
AU3083795A (en) Indoline and azaindoline derivatives as 5-ht1d alpha receptor agonists
AU3709097A (en) Amino compounds and angiotensin iv receptor agonists
ZA98484B (en) Use of beta3-adrenergic receptor agonists for the preparation of healing drugs